A challenging entity: multiple sclerosis or collagen tissue disorders: A case series of 6 patients
- PMID: 29201326
- PMCID: PMC5686314
- DOI: 10.22088/cjim.8.4.321
A challenging entity: multiple sclerosis or collagen tissue disorders: A case series of 6 patients
Abstract
Background: Multiple sclerosis and other demyelinating processes are sometimes difficult to differentiate from the neurological involvement in autoimmune diseases. Distinguishing multiple sclerosis from other lesions due to autoimmune diseases is crucial to avoid unsuitable or delayed treatments.
Methods: Charts of 6 patients diagnosed with mimicking multiple sclerosis between 1996 and 2014 were retrospectively assessed.
Results: The mean age at diagnosis was 35±7 years. The most commonly neurological manifestation at onset was paraparesis due to transverse myelopathy and uni/bilateral optic neuropathy. All our patients suffered from recurrent episodes of optic neuritis with a mean lag time of 12 months. Other initial presenting neurological manifestations in our patients included ataxic gait and pyramidal syndrome. Systemic symptoms occurred a long time before or after their initial neurological presentation. All patients had numerous T2 hyperintense lesions in the periventricular white matter and spinal cord with contrast enhancement. The antibodies tests revealed the presence of significant amounts of anti-nuclear antibodies. The anti-phospholipid antibodies were negative in all patients. All patients were treated with corticosteroid therapy and neurological features were cleared in all cases.
Conclusion: Multiple sclerosis, other myelitis and optic neuritis, are sometimes difficult to differentiate from CNS involvement in autoimmune disease. Indeed, the clinical presentation, immunological profile and MRI lesions may be similar.
Keywords: Autoimmunity; Collagen tissue disorders; Multiple sclerosis.
Figures






Similar articles
-
[Optic neuropathy in positive anti-MOG antibody syndrome].J Fr Ophtalmol. 2019 Dec;42(10):1100-1110. doi: 10.1016/j.jfo.2019.06.006. Epub 2019 Nov 12. J Fr Ophtalmol. 2019. PMID: 31732265 French.
-
Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.Medicine (Baltimore). 2004 Sep;83(5):280-291. doi: 10.1097/01.md.0000141099.53742.16. Medicine (Baltimore). 2004. PMID: 15342972
-
Demyelinating disease in SLE: is it multiple sclerosis or lupus?Best Pract Res Clin Rheumatol. 2013 Jun;27(3):405-24. doi: 10.1016/j.berh.2013.07.010. Best Pract Res Clin Rheumatol. 2013. PMID: 24238696 Review.
-
Non-MS autoimmune demyelination.Clin Neurol Neurosurg. 2008 Nov;110(9):905-12. doi: 10.1016/j.clineuro.2008.06.011. Clin Neurol Neurosurg. 2008. PMID: 18928881 Review.
-
[Demyelinating disorders].Medicina (B Aires). 2018;78 Suppl 2:75-81. Medicina (B Aires). 2018. PMID: 30199370 Spanish.
Cited by
-
Impairment, disability and fatigue in multiple sclerosis.Caspian J Intern Med. 2018 Summer;9(3):244-251. doi: 10.22088/cjim.9.3.244. Caspian J Intern Med. 2018. PMID: 30197769 Free PMC article.
References
-
- Brinar VV, Habek M, Zadro I. Current concepts in the diagnosis of transverse myelopathies. Clin Neurol Neurosurg. 2008;110:919–27. - PubMed
-
- Thong BY, Venketasubramanian N. A case of Sjögren's syndrome or multiple sclerosis? A diagnostic and therapeutic dilemma. Rheumatol Int. 2002;22:256–8. - PubMed
-
- Kurne A, Isikay IC, Karlioguz K, et al. A clinically isolated syndrome: a challenging entity: multiple sclerosis or collagen tissue disorders: clues for differentiation. J Neurol. 2008;255:1625–35. - PubMed
-
- Ferreira S, D’Cruz DP, Hughes GR. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology. 2005;44:434–42. - PubMed
Publication types
LinkOut - more resources
Full Text Sources